Mostrando 2 resultados de: 2
PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings
ArticleAbstract:Palabras claves:HCC, hepatocellular carcinoma, SCORE, SorafenibAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopusSorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis from the South American Liver Research Network
ArticleAbstract: Goals:We aim to describe the efficacy, safety profile, and variables associated with survival in patPalabras claves:hepatocellular carcinoma, Sorafenib, SOUTH AMERICA, SurvivalAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopus